Nil Guler

Pamukkale, 20070, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Elranatamab in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Study from Türkiye.

Elranatamab in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Study from Türkiye.

Journal: Journal of clinical medicine

Published: June 30, 2026

Role of 18F-FDG PET/CT Metabolic Parameters in Treatment Response Evaluation and Prognostic Assessment of Hodgkin Lymphoma: A Retrospective Analysis

Role of 18F-FDG PET/CT Metabolic Parameters in Treatment Response Evaluation and Prognostic Assessment of Hodgkin Lymphoma: A Retrospective Analysis

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: February 17, 2026

Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.

Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.

Journal: Leukemia research

Published: February 01, 2026

Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Dynamics as a Complementary Marker of Treatment Response in Newly Diagnosed Multiple Myeloma: A Prospective Analysis.

Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Dynamics as a Complementary Marker of Treatment Response in Newly Diagnosed Multiple Myeloma: A Prospective Analysis.

Journal: Cureus

Published: November 30, 2025

Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry

Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: July 23, 2025

Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: November 06, 2024

Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options.

Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options.

Journal: Research and practice in thrombosis and haemostasis

Published: May 08, 2024

GDF11 level and its effect on prognosis in patients with acute myeloid leukemia.

GDF11 level and its effect on prognosis in patients with acute myeloid leukemia.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Published: February 28, 2024

Incidence of and risk factors for venous thrombosis in hospitalized patients with hematologic malignancies: A single-center, prospective cohort study.

Incidence of and risk factors for venous thrombosis in hospitalized patients with hematologic malignancies: A single-center, prospective cohort study.

Journal: Northern clinics of Istanbul

Published: June 23, 2023

Radiation exposure in acute myeloid leukaemia, diffuse large B-cell lymphoma, and multiple myeloma patients in the first year following diagnosis.

Radiation exposure in acute myeloid leukaemia, diffuse large B-cell lymphoma, and multiple myeloma patients in the first year following diagnosis.

Journal: Polish journal of radiology

Published: July 27, 2022

Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors.

Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: July 13, 2022

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: September 15, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026